Edwards Lifesciences (EW) Experiences Rubust Heart Valve Sales, Analyst Sees Upside

February 5, 2013 1:05 PM

Jefferies today reiterated a Buy rating on Edwards Lifesciences (NYSE: EW) and raised its price target to $114.00 (from $100.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found